Virtu KCG Holdings LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtu KCG Holdings LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$12,000
-33.3%
19,936
-51.5%
0.00%
Q2 2016$18,000
-72.7%
41,102
+84.2%
0.00%
-100.0%
Q4 2015$66,000
+10.0%
22,319
+18.2%
0.00%0.0%
Q3 2015$60,000
-70.0%
18,877
-11.3%
0.00%
-66.7%
Q4 2014$200,000
+41.8%
21,276
+35.6%
0.00%
+50.0%
Q2 2014$141,00015,6850.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders